Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 15 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

5 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

Phase 3

3(33.3%)

N/A

3(33.3%)

Phase 4

2(22.2%)

Phase 2

1(11.1%)

9Total

Phase 3(3)

N/A(3)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials

NCT07535281Not ApplicableRecruiting

Effect of Complete Suction-Induced Collapse of the Renal Collecting System at the End of RIRS on Early Postoperative Outcomes

Role: lead

NCT07497867Recruiting

Long-term Prospective Study of Korean CADASIL Patients

Role: collaborator

NCT03431688Not ApplicableCompleted

Tailored Therapy for Clarithromycin-Resistant H. Pylori

Role: lead

NCT02112214Phase 3Active Not Recruiting

Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population

Role: collaborator

NCT05911711Unknown

Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients

Role: lead

NCT05729269Completed

Characterization of Gut Microbiota in Chronic Liver Disease With Decreased Muscle Mass

Role: collaborator

NCT01731665Recruiting

Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.

Role: collaborator

NCT03884348Completed

Tailored H. Pylori Eradication Based on Clarithromycin Resistance

Role: lead

NCT02532634Phase 4Completed

Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and Dexamethasone

Role: lead

NCT03357653Phase 3Unknown

Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1

Role: collaborator

NCT01167101Not ApplicableCompleted

Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection?

Role: lead

NCT01658020Phase 3Completed

A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg

Role: collaborator

NCT01259531Phase 4Completed

Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)

Role: collaborator

NCT01426126Phase 2Completed

Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum

Role: collaborator

NCT01212198Unknown

Korea National Diabetes Program

Role: collaborator

All 15 trials loaded